Our Team

Lorem ipsum

Simon worked as Consultant Surgeon at the Liverpool Head and Neck Centre with special interest in oncology and microvascular free tissue reconstruction between January 1999 to April 2022. From 2007 he had a funded secondment as professorial in the Faculty of Health, Social Care and Medicine at Edge Hill University.

He has published extensively with over 450 peer review papers and numerous book chapters. The main focus has been on the subject of patient reported outcome and quality of life. He was instrumental in the development of the UW-QOLv4 which was published in 2002. This questionnaire is one of the most commonly reported QOL questionnaires used in head and neck cancer.  http://www.handle-on-qol.com/Index.aspx

As the Chief Investigator, he has seen the successful completed a NIHR funded trial: ‘Improving quality of life through the routine use of the Patient Concerns Inventory for head and neck cancer patients: a cluster preference randomized controlled trial (NCT03086629). This trial produced 13 peer review publications.

Simon chaired the NHS England Quality of Life Metric Steering Group for many years. The Group successfully delivered full national roll-out in October 2021.This initiative is part of the ‘Achieving World-Class Cancer Outcomes: a strategy for England’.

From May 2022 Simon was appointed as a full-time consultant in the Department of Oral and Maxillofacial Surgery, at Wirral University Teaching Hospital. In October 2022 he was appointed as Clinical Lead for Research and Innovation at the Trust.

Simon remains research active through his links with the Liverpool Head and Neck Centre. He contributes to the Living Well After Head and Neck Cancer Research group.

https://www.researchgate.net/profile/Simon-Rogers-2

7,774 Research Interest Score, 17,122 Citations, 70 h-index (ORCID identifier: 0000-0002-5989-6142).

In 2024 Simon was awarded The Down Surgical Prize: The Down Surgical Prize is the most prestigious award given by the British Association of Oral and Maxillofacial Surgeons for excellence and outstanding contribution. The prize and Medal awarded annually, which will be considered a high honour, to be awarded to a person or persons who are adjudged to have made a major contribution to Oral and Maxillofacial Surgery in the widest sense.

Lorem ipsum

I am a Professor of Head and Neck Surgery and the University of Liverpool and an Honorary Consultant Otolaryngologist / Head and Neck Surgeon at Liverpool University Hospital NHS Foundation Trust.

In 2019, I was appointed as inaugural Director of the Liverpool Head & Neck Centre, the largest UK NHS/University collaboration delivering research-driven high-quality patient care. I have led the development of Transoral Laser Microsurgery as a standard of care for oropharynx cancer (OPSCC) and co-lead the international clinical trial, PATHOS, which will establish the safety and effectiveness of risk-stratified reduced dose (chemo)radiotherapy for patients undergoing transoral surgery for Human papillomavirus associated oropharynx cancer. Due to report in 2027, if PATHOS proves positive, it will result in global practice change for this patient group

I have secured >£18 million research funding and published >200 peer-reviewed papers, review articles and textbook chapters. I have edited two international reference textbooks (Scott-Brown, Head and Neck and Stell & Maran) as well as Clinical Otolaryngology, the leading UK ENT scientific journal. Research I led, directly influenced the UK government decision to vaccinate boys against Human papillomavirus (HPV), resulting in a predicted ~£0.54billion saving in NHS treatment costs.

I developed cadaveric courses in Transoral Laser Microsurgery Head & Neck surgery resulting in >100 surgeons being trained in the technique, raising the standard of transoral surgery for UK head & neck cancer patients.

Find out more

Lorem ipsum

Prof. Vincent GREGOIRE graduated as a Medical Doctor (MD) in 1987 from the Université Catholique de Louvain in Belgium. He was board certified in Radiation Oncology in Belgium in 1994 and obtained his PhD in Radiation Biology in 1996 after a fellowship at the Netherlands Cancer Institute in Amsterdam (The Netherlands) and at MD Anderson Cancer Center in Houston (USA).

Since his return from the USA, Prof. GREGOIRE was appointed at the Academic Hospital of the Catholic University of Louvain in Brussels (Belgium) where he was the Director of the Center for Molecular Imaging, Oncology and Radiotherapy, Full Professor in Radiation Oncology, and Head of Clinic in the Department of Radiation Oncology.

From May 1st 2018, Prof. Vincent GREGOIRE is the Head of the Radiation Oncology Dept. at the Léon Bérard Cancer Center in Lyon (France). He coordinates the Head and Neck Radiation Oncology program where the publication of the consensus guidelines for selection and delineation of target volumes brought him worldwide recognition.

Beside his clinical activities, Vincent GREGOIRE has been running a translational research program on tumor microenvironment, on the integration of functional and molecular imaging for treatment planning, and on the molecular basis of increased radiosensitivity in HPV-infected cells. Vincent GREGOIRE has directed or co-directed 15 PhD theses and has authored or co-authored more than 300 peer-reviewed publications and 16 book chapters. He has delivered close to 850 abstract presentations, lectures or teaching seminars worldwide, including award lectures such as the IFHNOS KK Ang lecture in 2014 and the Blair Hesketh BAHNO Memorial Lecture in 2015. He is member of the editorial board of Radiotherapy & Oncology and is a member of numerous scientific societies, including ASTRO and ESTRO, on which he serves on various committees. He has been the President of ESTRO from 2007 to 2009. Vincent GREGOIRE is the past vice-President of the board of EORTC, past-Chairman of the Radiation Oncology Group of the EORTC and of the Head & Neck group of the EORTC. Vincent GREGOIRE was acting chairman of an ICRU Report Committee on "dose prescription, specification and reporting in IMRT”. He has been nominated chairman of ICRU in October 2018. In 2008, he was awarded Honorary Fellow of the British Royal College of Radiology, and in 2016 Honorary Fellow of the Irish College of Radiology. In 2014 he received the Breur Award from ESTRO and in 2015, he was awarded Honorary ESTRO Physicist. In 2018, he received the Jens Overgaard legacy award from ESTRO.

Lorem ipsum